Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 389-394

  Aakre, Jennifer M ^a   Medoff, Deborah R ^a,b   Dixon, Lisa B ^a,b   Kreyenbuhl, Julie A ^a,b  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic medication; Hypoglycemic medication; Medication beliefs; Nonadherence; Serious mental illness; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BELIEFS ABOUT MEDICATION QUESTIONNAIRE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EFFECT SIZE; FEMALE; HEALTH BELIEF; HOSPITALIZATION; HUMAN; MAJOR AFFECTIVE DISORDER; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT DURATION;

EID: 84886058691     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S30975     Document Type: Article

References (24)

1. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol. 2003;23:389-399.
2. Byerly MJ, Nakonezny PA, Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatr Clin North Am. 2007;30: 437-452.
3. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;51:216-222.
4. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21:419-429.
5. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991;17:325-351.
6. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892-909.
7. Garavan J, Browne S, Gervin M, Lane A, Larkin C, O'Callaghan E. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr Psychiatry. 1998;39:215-219.
8. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med. 1992;22:787-797.
9. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:11-24.
10. Jónsdóttir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand. 2009;119:78-84.
11. Patel MX, Zoysa N, Bernadt M, David AS. A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry. 2008;69:1548-1556.
12. Dixon L, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26: 903-912.
13. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchi P. Diabetes mellitus in schizophrenic patients. Compr Psychiatry. 1996;37: 68-73.
14. Kreyenbuhl J, Dixon LB, McCarthy JF, Soliman S, Ignacio RV, Valenstein M. Does adherence to medications for Type 2 diabetes differ between individuals with versus without schizophrenia? Schizophr Bull. 2010;36:428-435.
15. Kreyenbuhl J, Leith J, Medoff DR, et al. A comparison of adherence to hypoglycemic medications between type 2 diabetes patients with and without serious mental illness. Psychiatry Res. 2011;188: 109-114.
16. Dixon LB, Kreyenbuhl JA, Dickerson FB, et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illness. Psychiatr Serv. 2004;55:892-900.
17. Beck E-M, Vogelin R, Wirtz M, Cavelti M, Kvrgic S, Vauth R. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs about Medication Questionnaire. J Nerv Ment Dis. 2012;200:33-43.
18. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-124.
19. Morris SB, DeShon RP. Combining effect size estimates in metaanalysis with repeated measures and independent-groups designs. Psychol Methods. 2002;7:105-125.
20. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatr Serv. 2007;58:207-212.
21. Dolder CR, Lacro JP, Jeste DV. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosom Med. 2003;65:156-162.
22. Pratt SI, Mueser KT, Driscoll M, Wolfe R, Bartels SJ. Medication nonadherence in older people with serious mental illness: prevalence and correlates. Psychiatr Rehabil J. 2006;29:299-310.
23. Velligan DI, Lam YW, Glahn DC, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull. 2006;32:724-742.
24. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.